Anthem Biosciences Announces Board Meeting to Approve Q1 Financial Results
Anthem Biosciences Limited, formerly known as Anthem Biosciences Private Limited, has scheduled a meeting of its Board of Directors to review and approve the financial performance for the quarter ended June 30, 2026.The Board meeting is set for Tuesday, July 21, 2026. The primary purpose of this gathering is to consider and subsequently approve the Unaudited Standalone and Consolidated Financial Results pertaining to the quarter ending June 30, 2026.
In addition to the board proceedings, the company has closed its trading window for Equity Shares. This closure was effective from July 01, 2026, until the close of trading hours on July 23, 2026. The extended trading restriction period corresponds to forty-eight hours following the declaration of the financial results for the quarter ended June 30, 2026.
ANTHEM Stock Price Movement
On Tuesday, shares of Anthem Biosciences Limited edged higher in the market, closing at ₹749.95 after gaining 0.30% over the session. The stock saw a total traded volume of 428,720 shares, with the security trading within its established price band.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.